Thank you for entrusting us with your medical care; we value your well-being. To that end, we
strive to keep you informed of the most up-to-date clinical research study opportunities. Our
practice is currently seeking volunteers for the following HIV-positive clinical research studies and you may be eligible.
If you believe that you may qualify for one of these studies, and are interested
in participating, please call our office at 404-355-3161. Our staff will be happy to
answer any questions you may have regarding your participation
This study offers patients doing well on an antiretroviral regimen of Reyataz®+Norvir®+Truvada® an option to possibly simplify their treatment. Researchers want to find out if you will continue to do well on your current HIV treatment regimen of Reyataz+Norvir+Truvada, or see how well you do if you change your regimen to Reyataz+Epzicom®, eliminating Norvir.
All medicines included in this study have been approved by the FDA to treat HIV.
You may qualify if you…
• Are at least 18 years of age
• Are HIV positive
• Are HLA-B*5701 negative (a blood test done in the office)
• Are doing well on an antiretroviral regimen of Reyataz+Norvir+Truvada
• Have good control of your HIV virus (have an undetectable viral load)
• Do not have Hepatitis B infection
What can you expect?
-No insurance is required. Participating in this clinical study provides 48 weeks of no cost study related care and study medication.
-You will also be compensated for time and travel.
-Two of three people participating in the study will simplify their ART regimen.
Maraviroc Observational (POEM)
This study is to follow individuals who are considering taking Selzentry (maraviroc) as part of their antiretroviral regimen.The purpose of the study is to help determine if patients taking Selzentry have more or less side effects or complications than those who do not take it.
The study will provide a free tropism assay- the test needed to determine if the HIV virus will respnd to Selzentry.
No medication is provided, and only the initial visit to draw the blood test is required.